We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $133B
1-Year Est. Return 43.5%
This Fund
S&P 500
This Quarter Est. Return
+14.19%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$117B
AUM Growth
+$9.87B
Cap. Flow
-$1.11B
Cap. Flow %
-0.95%
Top 10 Hldgs %
30.52%
Holding
4,391
New
216
Increased
2,182
Reduced
1,537
Closed
202

Top Buys

Rank Stock Value
1
COF icon
Capital One
COF
+$89.2M
2
FLUT icon
Flutter Entertainment
FLUT
+$43.9M
3
OKTA icon
Okta
OKTA
+$32.1M
4
CHWY icon
Chewy
CHWY
+$31.8M
5
COIN icon
Coinbase
COIN
+$26.9M

Sector Composition

Rank Sector Weight
1 Technology 31.83%
2 Financials 13.86%
3 Consumer Discretionary 10.91%
4 Healthcare 9.41%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SOC icon
1826
Sable Offshore Corp
SOC
$783M
$2.18M ﹤0.01%
99,053
+27,238
+38% +$634K
OUST icon
1827
Ouster
OUST
$3.45B
$2.18M ﹤0.01%
89,768
+8,293
+10% +$101K
MATW icon
1828
Matthews International
MATW
$722M
$2.17M ﹤0.01%
90,744
+1,031
+1% +$21.7K
CLDX icon
1829
Celldex Therapeutics
CLDX
$3.29B
$2.17M ﹤0.01%
106,599
+8,333
+8% +$162K
QS icon
1830
QuantumScape Corp
QS
$3.8B
$2.16M ﹤0.01%
321,802
+10,013
+3% +$42.3K
MRC
1831
DELISTED
MRC Global
MRC
$2.16M ﹤0.01%
157,501
+6,563
+4% +$79.1K
SXC icon
1832
SunCoke Energy
SXC
$799M
$2.15M ﹤0.01%
250,097
+8,121
+3% +$70.4K
CGON icon
1833
CG Oncology
CGON
$6.66B
$2.14M ﹤0.01%
82,424
+7,735
+10% +$186K
APGE icon
1834
Apogee Therapeutics
APGE
$10.2B
$2.14M ﹤0.01%
49,216
-5,169
-10% -$197K
BIRK icon
1835
Birkenstock
BIRK
$7.25B
$2.13M ﹤0.01%
43,405
+11,448
+36% +$588K
DLX icon
1836
Deluxe
DLX
$1.11B
$2.13M ﹤0.01%
133,881
+3,680
+3% +$55.4K
IIIN icon
1837
Insteel Industries
IIIN
$631M
$2.13M ﹤0.01%
57,157
+992
+2% +$33.1K
HSBC icon
1838
HSBC
HSBC
$356B
$2.12M ﹤0.01%
34,921
+672
+2% +$38.3K
GDYN icon
1839
Grid Dynamics Holdings
GDYN
$632M
$2.12M ﹤0.01%
183,251
+16,202
+10% +$213K
APLS
1840
DELISTED
Apellis Pharmaceuticals
APLS
$2.11M ﹤0.01%
122,002
-2,452
-2% -$45.4K
ACMR icon
1841
ACM Research
ACMR
$5.6B
$2.11M ﹤0.01%
81,465
+5,049
+7% +$114K
HAPN
1842
Happen Inc
HAPN
$2.27B
$2.11M ﹤0.01%
175,222
+6,442
+4% +$66.9K
ATRO icon
1843
Astronics
ATRO
$4.61B
$2.1M ﹤0.01%
75,341
+2,020
+3% +$47.2K
SPB icon
1844
Spectrum Brands
SPB
$2.06B
$2.09M ﹤0.01%
39,524
+11,420
+41% +$681K
OCUL icon
1845
Ocular Therapeutix
OCUL
$2.17B
$2.09M ﹤0.01%
225,548
+2,433
+1% +$19K
EVH icon
1846
Evolent Health
EVH
$534M
$2.09M ﹤0.01%
185,865
+15,947
+9% +$146K
ACH
1847
Accendra Health
ACH
$78.4M
$2.09M ﹤0.01%
229,629
+6,309
+3% +$46.5K
HELE icon
1848
Helen of Troy
HELE
$699M
$2.09M ﹤0.01%
73,507
+1,366
+2% +$41.9K
BLBD icon
1849
Blue Bird Corp
BLBD
$2.07B
$2.08M ﹤0.01%
48,279
+3,277
+7% +$125K
DFH icon
1850
Dream Finders Homes
DFH
$1.39B
$2.08M ﹤0.01%
82,881
+7,198
+10% +$162K

Similar funds

RhumbLine Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, RhumbLine Advisers held 4,391 positions worth $117B, up 9.2% from $107B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

RhumbLine Advisers's Q2 2025 filing shows 216 new, 2,182 increased, 1,537 reduced and 202 closed positions. Its largest new stake was Ralliant Corp: 320,982 shares worth $15.6M. The largest sale was Discover Financial Services, an estimated $91M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q2 2025 buy was Ralliant Corp: 320,982 shares worth $15.6M.
  • RhumbLine Advisers added most to Capital One in Q2 2025, an estimated $89.2M increase.
  • RhumbLine Advisers's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $75.5M.
  • RhumbLine Advisers fully exited Discover Financial Services in Q2 2025, selling an estimated $91M.
  • RhumbLine Advisers's ten largest holdings make up 31% of its $117B portfolio in Q2 2025.
  • RhumbLine Advisers opened 216 new positions and closed 202 in Q2 2025.
  • RhumbLine Advisers's portfolio value rose 9.2% quarter-over-quarter to $117B.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.